Beckcem Drug International Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.54 M
- Company Age 45 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.46 Cr
- Revenue Growth 8.73%
- Profit Growth 27.35%
- Ebitda 96.36%
- Net Worth 10.09%
- Total Assets 11.95%
About Beckcem Drug International
Beckcem Drug International Private Limited (BDIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 August 1979 and has a history of 45 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.54 M.
The company currently has active open charges totaling ₹1.46 Cr.
Gurvinderpal Baxi and Maninderpal Baxi serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1979PTC009758
-
Company No.
009758
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Aug 1979
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Beckcem Drug International Private Limited offer?
Beckcem Drug International Private Limited offers a wide range of products and services, including Dumbbell, Weight Plate & Accessories, Yoga Accessories, Orthopedic Equipment & Supplies, Upper Body Orthotic Devices, Rubber & Rubber Products, Rubber Sheets, Rehabilitation Equipment, Rehab Cushions, Movable Walker, Aluminum Walker.
Who are the key members and board of directors at Beckcem Drug International?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurvinderpal Baxi
|
Director | 15-Jun-1995 | Current |
|
Maninderpal Baxi
|
Director | 15-Jun-1995 | Current |
Financial Performance of Beckcem Drug International.
Beckcem Drug International Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.73% increase. The company also saw a substantial improvement in profitability, with a 27.35% increase in profit. The company's net worth Soared by an impressive increase of 10.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Beckcem Drug International?
In 2023, Beckcem Drug International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
G B Professional Associates Private LimitedManinderpal Baxi is a mutual person
Charges (Loans)
₹14.59 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.88 Cr
- Indian Overseas Bank : 0.48 Cr
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | Hdfc Bank Limited | ₹1.00 M | Open |
| 12 Oct 1998 | Indian Overseas Bank | ₹2.00 M | Open |
| 24 Mar 1994 | Indian Overseas Bank | ₹1.00 M | Open |
| 09 Mar 1994 | Others | ₹8.82 M | Open |
| 23 Dec 1991 | Indian Overseas Bank | ₹0.22 M | Open |
How Many Employees Work at Beckcem Drug International?
Beckcem Drug International has a workforce of 12 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Beckcem Drug International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beckcem Drug International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
